These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 17162376

  • 1. Safety and efficacy of vaccination against influenza in patients with rheumatoid arthritis.
    Elkayam O.
    Clin Dev Immunol; 2006; 13(2-4):349-51. PubMed ID: 17162376
    [Abstract] [Full Text] [Related]

  • 2. [Vaccination against influenza in patients with rheumatoid arthritis: clinical and antibody response].
    Francioni C, Rosi P, Fioravanti A, Megale F, Pipitone N, Marcolongo R.
    Recenti Prog Med; 1996 Apr; 87(4):145-9. PubMed ID: 8643873
    [Abstract] [Full Text] [Related]

  • 3. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.
    Del Porto F, Laganà B, Biselli R, Donatelli I, Campitelli L, Nisini R, Cardelli P, Rossi F, D'Amelio R.
    Vaccine; 2006 Apr 12; 24(16):3217-23. PubMed ID: 16466833
    [Abstract] [Full Text] [Related]

  • 4. Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
    Stojanovich L.
    Clin Dev Immunol; 2006 Apr 12; 13(2-4):373-5. PubMed ID: 17162380
    [Abstract] [Full Text] [Related]

  • 5. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
    Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, Comaneshter D, Levartovsky D, Mendelson E, Azar R, Wigler I, Balbir-Gurman A, Caspi D, Elkayam O.
    Ann Rheum Dis; 2008 Jul 12; 67(7):937-41. PubMed ID: 17981914
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases.
    Elkayam O, Ablin J, Caspi D.
    Autoimmun Rev; 2007 Apr 12; 6(5):312-4. PubMed ID: 17412304
    [Abstract] [Full Text] [Related]

  • 7. The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab.
    Arad U, Tzadok S, Amir S, Mandelboim M, Mendelson E, Wigler I, Sarbagil-Maman H, Paran D, Caspi D, Elkayam O.
    Vaccine; 2011 Feb 11; 29(8):1643-8. PubMed ID: 21211590
    [Abstract] [Full Text] [Related]

  • 8. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity.
    Chalmers A, Scheifele D, Patterson C, Williams D, Weber J, Shuckett R, Teufel A.
    J Rheumatol; 1994 Jul 11; 21(7):1203-6. PubMed ID: 7966058
    [Abstract] [Full Text] [Related]

  • 9. Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers.
    de Bruijn IA, Nauta J, Gerez L, Palache AM.
    Virus Res; 2004 Jul 11; 103(1-2):139-45. PubMed ID: 15163502
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases.
    Elkayam O, Amir S, Mendelson E, Schwaber M, Grotto I, Wollman J, Arad U, Brill A, Paran D, Levartovsky D, Wigler I, Caspi D, Mandelboim M.
    Arthritis Care Res (Hoboken); 2011 Jul 11; 63(7):1062-7. PubMed ID: 21425247
    [Abstract] [Full Text] [Related]

  • 11. The use of inactivated influenza vaccine in children.
    Wright PF.
    Semin Pediatr Infect Dis; 2006 Oct 11; 17(4):200-5. PubMed ID: 17055371
    [Abstract] [Full Text] [Related]

  • 12. The virosomal adjuvanted influenza vaccine.
    Calcagnile S, Zuccotti GV.
    Expert Opin Biol Ther; 2010 Feb 11; 10(2):191-200. PubMed ID: 20088714
    [Abstract] [Full Text] [Related]

  • 13. Influenza vaccination in patients with breast cancer: a case-series analysis.
    Vilar-Compte D, Cornejo P, Valle-Salinas A, Roldán-Marin R, Iguala M, Cervantes Y, López I.
    Med Sci Monit; 2006 Aug 11; 12(8):CR332-6. PubMed ID: 16865064
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML, Soriano-Fallas A, Umaña-Sauma MA, Ulloa-Gutierrez R, Arnoux S.
    Medicina (B Aires); 2007 Aug 11; 67(4):351-9. PubMed ID: 17891930
    [Abstract] [Full Text] [Related]

  • 15. Influenza vaccine for children.
    Neuzil KM.
    Clin Infect Dis; 2004 Mar 01; 38(5):689-91. PubMed ID: 14986253
    [No Abstract] [Full Text] [Related]

  • 16. Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients.
    Wallin L, Quintilio W, Locatelli F, Cassel A, Silva MB, Skare TL.
    Acta Reumatol Port; 2009 Mar 01; 34(3):498-502. PubMed ID: 19820674
    [Abstract] [Full Text] [Related]

  • 17. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.
    Nolan T, Richmond PC, Formica NT, Höschler K, Skeljo MV, Stoney T, McVernon J, Hartel G, Sawlwin DC, Bennet J, Ryan D, Basser RL, Zambon MC.
    Vaccine; 2008 Nov 25; 26(50):6383-91. PubMed ID: 18801398
    [Abstract] [Full Text] [Related]

  • 18. Preventive influenza vaccination for patients with rheumatoid arthritis. A need for an international campaign.
    Koutsogeorgopoulou L, Antoniadis C, Vassilopoulos D, Kassimos D.
    Clin Rheumatol; 2009 Jan 25; 28(1):103-4. PubMed ID: 18953623
    [No Abstract] [Full Text] [Related]

  • 19. Immunogenicity of influenza vaccine in children with pediatric rheumatic diseases receiving immunosuppressive agents.
    Ogimi C, Tanaka R, Saitoh A, Oh-Ishi T.
    Pediatr Infect Dis J; 2011 Mar 25; 30(3):208-11. PubMed ID: 20861757
    [Abstract] [Full Text] [Related]

  • 20. Live attenuated influenza vaccine in children.
    Ambrose CS, Walker RE, Connor EM.
    Semin Pediatr Infect Dis; 2006 Oct 25; 17(4):206-12. PubMed ID: 17055372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.